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FREQUENCY OF POLYPHARMACY AND RISK 
FACTORS IN THE ELDERLYIN BURDUR
BURDUR İLİNDE YAŞAYAN YAŞLILARDA 
POLİFARMASİ SIKLIĞI VE POLİFARMASİYİ 
ETKİLEYEN ETMENLER
Introduction: Polypharmacy is common among the elderly. This study aimed to determine 
the frequency of polypharmacy and the risk factors in the elderly.
Materials and Method: This cross-sectional study will be analysed in three stages 
(polypharmacy, drug characteristics and drug interaction). Herein, the first stage 
(polypharmacy) was conducted at Burdur city centre and the connected villages. A total of 400 
of 11,360 subjects aged ≥65 years who were registered with family physicians in Burdur city 
centre were selected using a systematic sampling method. A questionnaire of 30 questions 
about socio-demographic variables and rational drug use was distributed among the subjects. 
Subsequently, the subjects were asked to bring their own drugs from home that they were 
actively using or not currently using, and their drug-using behaviour was analysed via specific 
questions.
Results: The average number of different drugs possessed by the subjects at home was 
approximately 6 (5.95±4.30). A total of 64.9% of the drugs were used regularly, 21.3% were 
used occasionally and 13.8% were previously used but not currently used. The median 
number±standard deviation of the drugs that were used regularly, used occasionally and 
previously used but not currently used was 3.86±3.36, 1.27±1.75 and 0.82±1.82, respectively. 
According to the results of multivariate analysis, the presence of diabetes, hypertension, 
respiratory system or cardiovascular (except hypertension) diseases, visual impairment or 
hearing disorders significantly increased the total drug use (p<0.05).
Conclusion: Chronic diseases and living in the city centre are the main risk factors leading 
to polypharmacy. Therefore, interventions must be undertaken by monitoring and reducing 
chronic diseases and providing training on rational drug use in the provincial centres.
Key words: Polypharmacy; Aged; Chronic disease
Giriş: Polifarmasi yaşlılıkta çok sık görülür. Bu araştırmada Burdur ilinde yaşayan yaşlı 
bireylerde polifarmasi sıklığı ve neden olan risk faktörlerinin incelenmesi amaçlanmıştır. 
Gereç ve Yöntem: Kesitsel tipte planlanan polifarmasi, ilaçların özellikleri, ilaç etkileşimi 
aşamalı bir çalışmanın birinci aşamasının (polifarmasi) yer aldığı bu araştırma, Burdur ili merkezi 
ve merkeze bağlı köylerde gerçekleştirildi. Burdur ili merkezde aile hekimlerine kayıtlı 65 yaş ve 
üzeri 11360 kişiden 400’ü sistematik örneklem yöntemiyle seçilmiştir. Kişilere sosyodemografik 
değişkenler ve akılcı ilaç tutumuna yönelik 30 soruluk anket uygulandı ve ikinci aşamada 
kişilerin evlerinde bulunan ve kendilerine ait olan kullandıkları veya şu an kullanmadıkları 
ilaçları getirmeleri talep edildi ve ilaçları kullanma ile ilgili davranışları belirli sorularla irdelendi.
Bulgular: Kişilerin evlerinde kendilerine ait yaklaşık olarak ortalama 6 farklı etken 
maddeli ilaç (5.95±4.30) olduğu belirlendi. İlaçların %64,9’unu düzenli olarak, %21.3’ünü 
ara sıra kullanılmakta ve %13.8’ini ise önceden kullanmış ancak şu anda kullanılmamakta 
olduğu saptandı. Düzenli olarak kullanılan, ara sıra kullanılan ve önceden kullanılmış olup 
şimdi kullanılmayan ilaç sayısı ortalaması ve standart sapması sırasıyla; 3.86±3.36, 1.27±1.75, 
0.82±1.82’dir. Polifarmasi (5 ve üzeri aktif olarak ilaç kullanma) sıklığı %36.5’dir. Multivariate 
analiz sonuçlarına göre, kişide diyabet, hipertansiyon, solunum sistemi veya kardiyovasküler 
sistem (hipertansiyon dışı) hastalığı bulunması, görme bozukluğu yaşaması veya işitme 
rahatsızlığı bulunması toplam ilaç kullanımını anlamlı şekilde arttırmıştır (p<0.05).
Sonuç: Polifarmasiye yol açan asıl etkenin kronik hastalıklar ve kent merkezinde yaşam 
olduğu saptanmıştır; dolayısıyla kronik hastalıkların takibi ve azaltılmasına yönelik uygulamalar 
ve il merkezlerine akılcı ilaç kullanımı konusunda eğitim verilerek müdahale edilmesi 
gerekmektedir. 
Anahtar sözcükler: Polifarmasi; Yaşlı; Kronik hastalık
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INTRODUCTION
The population over the age of 65 years has been 
growing rapidly as a result of the demographic 
transformation of the world and Turkey. The global 
elderly population, which was approximately 534 
million in 2010, is estimated to be approximately 1.5 
billion (mostly in developing countries) in 2050 (1).
In Turkey, the elderly population (age≥65 years) 
was 5,891,694 in 2013. In the last 5 years, it increased by 
17% and reached 6,895,385 in 2017. The ratio between 
the elderly population and the total population was 
7.7% in 2013 and increased to 8.5% in 2017. Based on 
future population estimates by the Turkish Statistical 
Institute, the ratio of elderly population is expected to 
be 10.2% in 2023, 12.9% in 2030, 16.3% in 2040, 22.6% 
in 2060 and 25.6% in 2080 (2).
Along with increase in the life expectancy, 
there have been changes in the causes of diseases 
and deaths. At the dawn of the 20th century, the 
major health threats were infectious and parasitic 
diseases that most often claimed the lives of infants 
and children. Currently, non-communicable diseases 
that more commonly affect adults and older people 
impose the greatest burden on global health. As a 
result, elderly people refer more to physicians due 
to increase in the number of elderly people with 
prolonged life expectancy, the multiplicity of comorbid 
diseases and increase in the need for health care. This 
may cause the elderly population to be in the forefront 
of drug consumption. The need for long-term use of 
drugs due to chronic diseases leads to concomitant 
use of certain drugs. Besides, undesirable side effects 
of drugs can easily occur owing to long-term use, 
drug-drug interactions and age-related changes in 
metabolic processes. For these reasons, the use of 
multiple drugs leads to a vicious circle that is difficult 
to break, if not prevented, in the elderly (3).
Polypharmacy (multi-drug use) has different 
definitions and can be expressed as the use of ≥4–5 
drugs per day, the use of drugs more than those that 
are clinically indicated and the use of at least one 
unnecessary drug (4). The incidence of polypharmacy 
increases with age and also varies among countries. 
Study in the United States of America (USA) report 
that 23% of women aged over 65 years living in the 
community and 35%–40% of those aged 75–85 years 
have been shown to use ≥5 drugs (5). In the United 
Kingdom, 36% of individuals aged over 75 years have 
been shown to use ≥4 drugs per day (6). In Turkey, 
although there are no comprehensive data concerning 
the elderly living in the community, in studies among 
patients admitted to polyclinics, the rate of using ≥5 
drugs was found to be 63.2% for women and 55.3% for 
men aged over 65 years. According to this study, the 
average number of drugs used per person was 4.5 and 
the use of ≥10 drugs was 7.9% (7).
The present study aimed to determine the 
frequency of polypharmacy and the risk factors in the 
elderly (aged ≥65 years).
MATERIALS AND METHOD 
This cross-sectional study will be analysed in three 
stages (polypharmacy, drug characteristics and drug 
interaction). Herein, the first stage (polypharmacy) was 
conducted at Burdur city centre and the connected 
villages. The study population comprised 11,360 
subjects, after excluding individuals who are in prison 
(12 individuals) and those whose residence is outside 
the city centre (519 individuals) from 11,900 subjects 
aged ≥65 years who were registered with 28 family 
physicians in Burdur city centre. Considering the 
population of 11,360 individuals, prevalence of 50%, 
sampling error rate of 0.05 and confidence interval of 
95.0%, the minimum sample size, which represents the 
population in the Epi info programme, was calculated 
to be 378. A total of 400 subjects were decided to be 
included in the study. The subjects to be sampled were 
selected by listing them as those who are registered 
with 1st family physicians to those who are registered 
with 28th family physicians (to protect regional factors 
as much as possible) using a systematic sampling 
method. A backup for each person was also identified. 
Because 13 individuals could not be reached, 
predefined back-ups were contacted. A pre-test was 
performed on 10 subjects (aged >65 years), who 
dropped out from the selected samples and back-ups 
selected before the research, and the questions were 
revised. The dependent variable of the study included 
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the total number of different drugs used by the 
subjects, whereas the independent variables included 
the rational drug use, attitudes and behaviours of the 
elderly and the general socio-demographic variables. 
First, a questionnaire of 30 questions about socio-
demographic variables and rational drug use was 
distributed among the subjects. Second, the subjects 
were asked to bring their own drugs from home that 
they were actively using or not currently using. Their 
drug-using behaviour was then analysed via specific 
questions. Before data collection, training was 
provided to midwives and nurses who would collect 
the data to fill the questionnaire in order to ensure 
standardisation. Home visits were conducted by 
community health centre midwives and nurses who had 
previously received training and had field experience, 
and face-to-face interviews and questionnaires were 
conducted for subjects who provided consent to 
participate in the survey. Survey forms were filled by 
midwives and nurses. Data were collected between 
May 2016 and June 2016, and the obtained data 
were recorded electronically for statistical analysis 
using SPSS 22.0 statistical analysis software (SPSS Inc. 
Chicago, IL, USA). Quantitative data were represented 
as arithmetic average and standard deviation, and 
count data were represented as number (percentage). 
The chi-square test and Student’s t-test were used 
for the analysis of variables, and logistic regression 
(backward LR) was used for multivariate analysis. The 
results were evaluated using a 95% confidence interval, 
and p<0.05 was considered statistically significant. 
Medical ethics committee approval was obtained 
from Başkent University Medical and Health Sciences 
(date: 17 May 2016, protocol number: KA16/215). 
After obtaining the necessary permits, the permission 
of Burdur Governorship Public Health Directorate 
was also obtained (date: 20 May 2016 and number 
of the permission file: 13124672/663.08), and the 
implementation of the research was started.
RESULTS
This study included a total of 400 subjects aged ≥65 
years, among which 64.0% lived in the city centre, 
57.0% were women and 45.2% were aged ≥75 years. 
Furthermore, 64.2% of the subjects were married 
and 25.2% had no social security. Only 9.7% of the 
subjects graduated from secondary school and higher 
education institutions. During the study, subjects aged 
>65 years were asked to bring all their medications 
from home, and the medications were recorded 
according to their different types. A total of 2,378 
different drugs were found to be possessed by the 
400 subjects. The average number of different drugs 
possessed by the subjects at home was approximately 
6 (5.95±4.30). A total of 64.9% of the drugs were used 
regularly, 21.3% were used occasionally and 13.8% 
were previously used but not currently used. The 
median number±standard deviation of the drugs that 
were used regularly, occasionally used and previously 
used but not currently used was 3.86±3.36, 1.27±1.75 
0.82±1.82, respectively. The frequency of polypharmacy 
(active use of ≥5 drugs) was 36.5%.
The results of univariate analysis performed to 
evaluate factors affecting polypharmacy in the elderly 
showed that the following were statistically significant 
risk factors responsible for increasing the frequency 
of polypharmacy: decreased number of people living 
in the house; female sex; age>75 years; those living 
in city centres; those who are widowed, single or 
separated; those living in nursing homes; diabetes; 
hypertension; heart problems; hearing problems; 
visual problems; chronic respiratory disorders; history 
of urinary incontinence and falling in the last 6 months 
and total number of illnesses and findings observed 
in the subject. The following factors did not have 
a statistically significant effect on polypharmacy in 
this age group: education status, presence of social 
security and income status, making the doctor 
prescribe medication without being sick, rheumatism, 
hernia, osteoarthritis and osteoporosis, gastrointestinal 
disorders, history of faecal incontinence, presence 
of disability report and nervous system disorders 
(Alzheimer, parkinson, vertigo, paralysis, etc.) (Table 1). 
According to the results of multivariate analysis, 
the presence of diabetes, hypertension, respiratory 
system or cardiovascular system (except hypertension) 
diseases; visual impairment or hearing disorder 
significantly increased the total drug use (p<0.05) 
(Table 2). 
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Table 1. Effect of descriptive factors on polypharmacy.
Characteristics
Total
(n=400, 
|%100.0|)
Polypharmacy 
is absent (0–4 
medications) 
(n=254|%63.5|)
Polypharmacy 
is present (≥5 
medications) 
(n=146 |%36.5|)
p
Sex (Female) 228 (57.0) 132 (52.0) 96 (65.8) 0.007
Age (years | mean±sd) 74.5±6.8 73.9±6.8 75.6±6.7 0.017
Living place (city centre) 256 (64.0) 150 (59.1) 106 (72.6) 0.007
Marital status (married) 257 (64.3) 177 (69.7) 80 (54.8) 0.003
Education status 
Illiterate
Literate 
 Primary school graduate
Secondary school graduate and higher
78 (19.5)
49 (12.3)
234 (58.5)
39 (9.7)
44 (17.3)
29 (11.4)
158 (62.2)
23 (9.1)
34 (23.3)
20 (13.7)
76 (52.1)
16 (11.0)
0.255
Has social security 299 (74.8) 194 (76.4) 105 (71,9) 0.323
Income status
 Not enough
Barely enough
Easily earn a livelihood
89 (22.3)
187 (46.8)
124 (31.0)
52 (20.5)
120 (47.2)
82 (32.3)
37 (25.3)
67 (45.9)
42 (28.8)
0.498
Lives at home with
Only partner
      Partner and relatives*
Only relatives
Alone 
Nursing home 
206 (51.5)
51 (12.8)
54 (13.5)
72 (18.0)
17 (4.2)
142 (55.9)
35 (13.8)
32 (12.6)
38 (15.0)
7 (2.8)
64 (43.8)
16 (11.0)
22 (15.1)
34 (23.3)
10 (6.8)
0.028
The number of people living at home (mean±sd) 2.2±1.2 2.3±1.2 2.1±1.1 0.044
Making the doctor prescribe medication without 
being sick 174 (43,5) 114 (44.9) 60 (41.1) 0.462
Diabetes 82 (20.5) 30 (11.8) 52 (35.6) <0.001
Hypertension 201 (50.3) 97 (38.2) 104 (71.2) <0.001
Cardiovascular disease (except hypertension) 123 (30.8) 42 (16.5) 81 (55.5) 0.000
Cancer 7 (1.8) 3 (1.2) 4 (2.7) 0.264
Vision impairment 305 (76.2) 188 (74.0) 117 (80.1) <0.001
Hearing problem 166 (41.5) 87 (34.3) 79 (54.1) <0.001
Respiratory tract disorders 46 (11.5) 19 (7.5) 27 (18.5) 0.001
Rheumatism, herniated disc, osteoarthritis and 
osteoporosis
122 (20.5) 82 (32.3) 40(27.4) 0.307
Gastrointestinal tract disorders 46 (11.5) 27 (10.6) 19 (13.0) 0.472
Nervous system disorders (Alzheimer, Parkinson, 
vertigo, paralysis, etc.) 47 (11.8) 28 (11.0) 19 (13.0) 0.552
Stroke history 56 (14.0) 28 (11.0) 28 (19.2) 0.024
Stress incontinence 155 (38.8) 81 (31.9) 74 (50.7) <0.001
Urge incontinence 168 (42.0) 93 (36.6) 75 (51.4) 0.004
Faecal incontinence 27 (6.8) 16 (6.3) 11 (7.5) 0.636
Fall in last 6 months 95 (23.8) 52 (20.5) 43 (29.5) 0.042
Disability reports 5 (1.2) 1 (0.4) 4 (2.7) 0.062
Total number of illnesses and findings in the per-
son (mean±sd) 3.8±1.9 3.2±1.8 4.9±1.5 <0.001
*** Do you ask your doctor to prescribe medication without being sick or do you buy it and keep it at home thinking it might be necessary?
* Relatives: children, grandchildren and other people.
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Table 2. Factors affecting polypharmacy.
Factor OR (95%, CI) p
Living place (province centre, village ref.)
Diabetes (present, absent ref.)
Hypertension (present, absent ref.)
Cardiovascular (except hypertension) diseases (present, absent 
ref.)
Hearing problem (present, absent ref.)
Chronic respiratory disorder (present, absent ref.)
1.816 (1.054–3.130)
3.239 (1.800–5.828)
2.689 (1.621–4.460)
4.923 (2.928–8.277)
2.226 (1.409–3.873)
2.934 (1.407–6.120)
0.032
<0.001
<0.001
<0.001
0.001
0.004
Backward LR logistic regression, −2Log likelihood: 370.543, Nagelkerke R Square: 0.438, variables  in the equation: 
p=0.000, wald: 28.426.
OR: odds ratio; CI: confidence interval
DISCUSSION
In our study group, the frequency of polypharmacy 
(active use of ≥5 drugs) was 36.5%, which was 
considered as a significant problem. The incidence 
of polypharmacy increases with age and varies 
between countries, and it is reported to be 
approximately 35%–40% in the elderly aged >75 
years (8,9). The frequency of polypharmacy also 
varies between the elderly living in the community 
and the elderly living in the nursing home. Among 
the patients living in the community, the incidence 
rates of 41%, 43.4%, 35.8% and 46.8% were reported 
from Iceland, USA, Australia and Italy, respectively 
(10-12). In a recent study conducted among nursing 
homes as a report of shelter work in eight European 
countries, the incidence rate was reported to be 
49.7% (13). In the study conducted by Arslan et al., 
it was found that 28.2% of the participants were 
using one drug, 24.3% two drugs, 18.5% three 
drugs, 11.7% four drugs and 17.3% five or more 
drugs (14). Gurol Arslan et al. revealed that 35% of 
the elderly were using 5–6 drugs and the number 
of drugs used by them was 4.5±1.8 (15). In the study 
conducted by Kutsal et al. in 2006 on multiple drug 
use by interviewing 1,433 elderly aged ≥65 years, 
84.7% of the elderly who participated in the survey 
had at least one drug that was regularly used 
and 15.3% did not have any; furthermore, 23.2% 
of the subjects stated that they were using only 
one drug, 17% two drugs, 19.2% three drugs and 
38.2% four and more drugs (16). In the study by 
Arslan et al. (15) evaluating drug use in patients 
aged ≥65 years, there was no significant difference 
between male and female patients in terms of the 
amount of drugs used; 11.7% of the elderly were 
using four drugs and 17.3% were using five or more 
drugs. The results of univariate analysis showed 
that polypharmacy was more common in women. 
Based on the results of multivariate analysis, it 
was found that the presence of chronic diseases 
in general was the main risk factor. Longer life 
expectancy and higher frequency of chronic illness 
in women, especially those aged >65 years, were 
risk factors for using multiple drugs. There are 
many factors driving polypharmacy. Some studies 
have shown a relationship between polypharmacy 
and both female sex and age>80 years (17,18). 
In our study, there was no relationship between 
socio-demographic factors and polypharmacy. 
This may have been due to the characteristics of 
the study group.
As a general outcome of the study, the 
presence of chronic diseases that increase with age 
leads to polypharmacy. Because chronic diseases, 
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especially hypertension, is both frequent and 
leads to the use of multiple drugs in the relevant 
age group, it is considered an important problem 
that needs to be addressed. Approximately half of 
those participating in the study and 71.2% of those 
with polypharmacy have hypertension. In the study 
by Ozturk et al. evaluating the drug use in patients 
aged >65 years, the amount of subjects using 
four and more drugs was 46.7% and similarly the 
frequency of hypertension was 48.1% (19). In the 
study conducted by Iscigil et al., in which the elderly 
living in nursing homes and patients who applied to 
university polyclinics were studied and compared 
based on their drug use, antihypertensives were 
reported as the most commonly used drugs (20). 
Ozturk et al. also found that the frequency of 
hypertension was high (approximately 50%) in 
the elderly, and it was one of the significant risk 
factors of polypharmacy (21). Diabetes, one of the 
chronic diseases, also emerged as a significant 
public health problem with a frequency of 20.5% 
in the study group. In addition, approximately 35% 
of those who used multiple drugs and 11.8% of 
those who did not use any drugs had diabetes. In 
our study, diabetes was considered to be another 
significant risk factor of polypharmacy. Similarly, 
in the study by Ozturk et al., the frequency of 
diabetes was found to be 23.2% in the elderly (19). 
Arslan et al. found that the frequency of diabetes 
was 10.2% in the elderly living in the nursing home 
(15). In the study by Oztürk et al. examining the 
factors affecting polypharmacy in the elderly, the 
frequency of diabetes was found to be 39.0% in 
the study group, 49.0% in the polypharmacy group 
and 24.0% in the non-polypharmacy group (21). 
It is understood that diabetes is one of the major 
disease groups, which requires intervention, in 
terms of rational drug use. In other foreign studies, 
similarly to our study, it has been found that 
diabetes and hypertension lead to polypharmacy 
(22-23). In our study, the number of elderly people 
with hearing impairment, which was diagnosed 
based on the Problems and Expectations of 
People with Disabilities study (2010), was found to 
be significantly higher than that of people aged 
≥65 years (7.7%) (24). This difference is considered 
to be attributed to the fact that those with mild 
hearing loss, who do not require hearing aids, were 
also included in our study as those with hearing 
problems. Hearing problems can also trigger 
polypharmacy as it appears with other chronic 
diseases. Another factor affecting polypharmacy 
was chronic respiratory diseases; 11.5% of the study 
group and 18.5% of those with polypharmacy had 
chronic respiratory disease. In patients with such 
chronic conditions, the problem of multiple and 
long-term drug use is prevalent. 
In our study, polypharmacy was found to be 
higher in subjects who live in the city centre. Studies 
have shown that elderly people living in urban 
areas have more tendency toward polypharmacy 
due to the following: the ease of access to health 
services, the tendency of patients to visit different 
doctors and take many prescriptions, the presence 
of excess drug expectations, the use of medication 
for symptoms rather than diagnosis, the tendency 
of doctors to terminate current medication and start 
a new one, the large number of non-prescription 
drug sales without awareness of the physicians and 
the tendency of elderly patients to use medications 
taken from family members or surroundings (25). 
Doctor or Physicians; which one?
In conclusion, the prevention of chronic 
diseases, which is considered as the main cause 
of polypharmacy in the elderly, the adaptation of 
a rational drug use approach by physicians and 
the follow-up and regulation of drugs by family 
physicians, especially for the elderly with chronic 
diseases, are shown to be necessary to maintain 
multiple drug use at a certain level. We recommend 
trainings on rational drug use in city centres and 
then in rural areas and preventing patients from 
taking drugs from pharmacies in an uncontrolled 
manner.
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